212 related articles for article (PubMed ID: 26762281)
1. Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia.
Boerlage TC; van Hees CL; Huitema AD; Lauw FN
Obes Surg; 2016 Mar; 26(3):688-90. PubMed ID: 26762281
[TBL] [Abstract][Full Text] [Related]
2. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study.
Coblijn UK; Lagarde SM; de Castro SM; Kuiken SD; van Tets WF; van Wagensveld BA
Surg Obes Relat Dis; 2016 Feb; 12(2):246-52. PubMed ID: 26381875
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: A national survey of surgeon practices.
Giannopoulos S; Athanasiadis DI; Clapp B; Lyo V; Ghanem O; Puzziferri N; Stefanidis D;
Surg Obes Relat Dis; 2023 Apr; 19(4):303-308. PubMed ID: 36379840
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole Absorption and Fasting Gastrinemia After Roux-en-Y Gastric Bypass.
Collares-Pelizaro RVA; Santos JS; Nonino CB; dos Reis Dias LA; Gaitani CM; Salgado W
Obes Surg; 2017 Sep; 27(9):2303-2307. PubMed ID: 28397104
[TBL] [Abstract][Full Text] [Related]
5. Acid-related complications after laparoscopic Roux-en-Y gastric bypass: risk factors and impact of proton pump inhibitors.
Wennerlund J; Gunnarsson U; Strigård K; Sundbom M
Surg Obes Relat Dis; 2020 May; 16(5):620-625. PubMed ID: 32107170
[TBL] [Abstract][Full Text] [Related]
6. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years.
Ward EK; Jensen-Otsu E; Schoen JA; Rothchild K; Mitchell B; Austin GL
Surg Obes Relat Dis; 2015; 11(3):585-90. PubMed ID: 25553887
[TBL] [Abstract][Full Text] [Related]
7. Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study.
Garrido AB; Rossi M; Lima SE; Brenner AS; Gomes CA
Arq Gastroenterol; 2010; 47(2):130-4. PubMed ID: 20721455
[TBL] [Abstract][Full Text] [Related]
8. Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey.
Steinemann DC; Bueter M; Schiesser M; Amygdalos I; Clavien PA; Nocito A
Obes Surg; 2014 May; 24(5):741-6. PubMed ID: 24347350
[TBL] [Abstract][Full Text] [Related]
9. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
10. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.
Thereaux J; Lesuffleur T; Czernichow S; Basdevant A; Msika S; Nocca D; Millat B; Fagot-Campagna A
Surg Obes Relat Dis; 2017 Jun; 13(6):951-959. PubMed ID: 28223087
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass.
Kang X; Zurita-Macias L; Hong D; Cadeddu M; Anvari M; Gmora S
Surg Obes Relat Dis; 2016 Jun; 12(5):1003-1007. PubMed ID: 26948448
[TBL] [Abstract][Full Text] [Related]
13. Is open-capsule proton pump inhibitor associated with faster healing time for marginal ulceration after Roux-en-Y gastric bypass?
Yoo H; Firkins SA; Kwon AG; Imperio-Lagabon K; Bajwa R; Flora B; Simons-Linares CR
Surg Obes Relat Dis; 2024 Mar; 20(3):254-260. PubMed ID: 37996260
[TBL] [Abstract][Full Text] [Related]
14. Response to letter to the editor Re: The effect of PPI use on human gut microbiota and weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass.
Austin GL; Ward EK
Obes Surg; 2015 Jun; 25(6):1070. PubMed ID: 25860132
[No Abstract] [Full Text] [Related]
15. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.
Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR
Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522
[TBL] [Abstract][Full Text] [Related]
17. Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass?
D'Hondt MA; Pottel H; Devriendt D; Van Rooy F; Vansteenkiste F
Obes Surg; 2010 May; 20(5):595-9. PubMed ID: 20058097
[TBL] [Abstract][Full Text] [Related]
18. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
20. Hypomagnesemia associated with a proton pump inhibitor.
Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H
Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
